Bioorganic & Medicinal Chemistry Letters

Papers
(The H4-Index of Bioorganic & Medicinal Chemistry Letters is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Revisiting the dipeptidyl carboxypeptidase inhibitor captopril as a source of pan anti-trypanosomatid agents157
Design, synthesis and biological evaluation of alginate oligosaccharide derivatives86
Design, synthesis and biological evaluation of tanshinone IIA derivatives as NLRP3 inflammasome inhibitors83
Studies on in vitro modulatory effects to base excision repair enzymes induced by small molecule binding to Deaminated CAG repeat hairpin62
Discovery of DS-1093a: An oral hypoxia-inducible factor prolyl hydroxylase inhibitor for the treatment of renal anemia59
Epigallocatechin and epigallocatechin-3-gallate are not inhibitors of tyrosinase53
Editorial Board46
Armeniaspirol analogues disrupt the electrical potential (ΔΨ) of the proton motive force44
Pyrazolo-1-carbothioamides as EGR-1–DNA binding disruptors38
Non-alkylator anti-glioblastoma agents induced cell cycle G2/M arrest and apoptosis: Design, in silico physicochemical and SAR studies of 2-aminoquinoline-3-carboxamides34
Design of 99mTc-labeled zinc-chelating imaging probe for SPECT imaging of the pancreas34
Discovery of structural diverse reversible BTK inhibitors utilized to develop a novel in vivo CD69 and CD86 PK/PD mouse model33
Phytochemical investigation of Asarum sieboldii var. seoulense and the phenotypic profiles of its constituents against a Parkinson’s Disease olfactory cell line31
Improved synthesis and anticancer activity of a potent neuronal nitric oxide synthase inhibitor30
Discovery of 3-amino-4-{(3S)-3-[(2-ethoxyethoxy)methyl]piperidin-1-yl}thieno[2,3-b]pyridine-2-carboxamide (DS96432529): A potent and orally active bone anabolic agent28
Design, synthesis and characterizations of prodrugs of brexanolone28
Development of a highly potent and selective degrader of LRRK227
Design and structural optimization of thiadiazole derivatives with potent GLS1 inhibitory activity26
Editorial Board25
SARS-CoV-2 papain-like protease (PLpro) inhibitory and antiviral activity of small molecule derivatives for drug leads24
Editorial Board24
New class of fused [3,2-b][1,2,4]triazolothiazoles for targeting glioma in vitro24
Enteroviral replication inhibition by N-Alkyl triazolopyrimidinone derivatives through a non-capsid binding mode24
Synthesis and characterization of chiral 6-azaspiro[2.5]octanes as potent and selective antagonists of the M4 muscarinic acetylcholine receptor24
0.12043309211731